Diagnosis and management of Waldenström macroglobulinaemia-A British Society for Haematology guideline.

Pratt, Guy; El-Sharkawi, Dima; Kothari, Jaimal; D'Sa, Shirley; Auer, Rebecca; McCarthy, Helen; Krishna, Rajesh; Miles, Oliver; Kyriakou, Charalampia; Owen, Roger

Pratt, Guy; El-Sharkawi, Dima; Kothari, Jaimal; D'Sa, Shirley; Auer, Rebecca; McCarthy, Helen; Krishna, Rajesh; Miles, Oliver; Kyriakou, Charalampia; Owen, Roger.

Afiliación

Pratt G; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
El-Sharkawi D; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
Kothari J; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
D'Sa S; University College London Hospitals NHS Foundation Trust, London, UK.
Auer R; Barts Health NHS Trust, London, UK.
McCarthy H; University Hospitals Dorset NHS Foundation Trust, Dorset, UK.
Krishna R; University Hospitals of Leicester NHS Trust, Leicester, UK.
Miles O; Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.
Kyriakou C; University College London Hospitals NHS Foundation Trust, London, UK.
Owen R; London North West University Healthcare NHS Trust, London, UK.

Br J Haematol ; 197(2): 171-187, 2022 04.

Article en En | MEDLINE | ID: mdl-35020191

Asunto(s)

Hematología; Macroglobulinemia de Waldenström; Clorhidrato de Bendamustina/uso terapéutico; Bortezomib/uso terapéutico; Humanos; Rituximab/uso terapéutico; Macroglobulinemia de Waldenström/tratamiento farmacológico; Macroglobulinemia de Waldenström/terapia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Macroglobulinemia de Waldenström / Hematología Tipo de estudio: Diagnostic_studies / Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google